Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081371249> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2081371249 endingPage "160" @default.
- W2081371249 startingPage "153" @default.
- W2081371249 abstract "Despite demonstrated efficacy of ε-aminocaproic acid (EACA) in reducing blood loss in adolescents undergoing spinal fusion, there are no population-specific pharmacokinetic data to guide dosing. The aim of this study was to determine the pharmacokinetics of EACA in adolescents undergoing spinal fusion surgery and make dosing recommendations.Twenty children ages 12–17 years were enrolled, with 10 children in each of two groups based on diagnosis (idiopathic scoliosis or non-idiopathic scoliosis). Previously reported data from infants undergoing craniofacial surgery were included in the model to enable dosing recommendations over a wide range of weights, ages, and diagnoses. A population non-linear mixed effects modelling approach was used to characterize EACA pharmacokinetics.Population pharmacokinetic parameters were estimated using a two-compartment disposition model with allometrically scaled weight and an age effect on clearance. Pharmacokinetic parameters for the typical patient were a plasma clearance of 153 ml min−1 70 kg−1 (6.32 ml min−1 kg−0.75), intercompartmental clearance of 200 ml min−1 70 kg−1 (8.26 ml min−1 kg−0.75), central volume of distribution of 8.78 litre 70 kg−1 (0.13 litre kg−1), and peripheral volume of distribution of 15.8 litre 70 kg−1 (0.23 litre kg−1). Scoliosis aetiology did not have a clinically significant effect on drug pharmacokinetics.The following dosing schemes are recommended according to patient weight: weight <25 kg, 100 mg kg−1 loading dose and 40 mg kg−1 h−1 infusion; weight ≤25 kg–<50 kg, 100 mg kg−1 loading dose and 35 mg kg−1 h−1 infusion; and weight ≥50 kg, 100 mg kg−1 loading dose and 30 mg kg−1 h−1 infusion. An efficacy trial employing this dosing strategy is warranted.NCT01408823." @default.
- W2081371249 created "2016-06-24" @default.
- W2081371249 creator A5012517193 @default.
- W2081371249 creator A5021004651 @default.
- W2081371249 creator A5029412010 @default.
- W2081371249 creator A5030371492 @default.
- W2081371249 date "1959-05-01" @default.
- W2081371249 modified "2023-10-18" @default.
- W2081371249 title "Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by ϵ-aminocaproic acid" @default.
- W2081371249 cites W1546853254 @default.
- W2081371249 cites W1993114358 @default.
- W2081371249 cites W1998987293 @default.
- W2081371249 cites W2021322041 @default.
- W2081371249 cites W2031592293 @default.
- W2081371249 cites W2054979333 @default.
- W2081371249 cites W2081812343 @default.
- W2081371249 cites W2172065400 @default.
- W2081371249 cites W2198971740 @default.
- W2081371249 cites W2270021424 @default.
- W2081371249 cites W58221375 @default.
- W2081371249 doi "https://doi.org/10.1016/0003-9861(59)90100-6" @default.
- W2081371249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13650650" @default.
- W2081371249 hasPublicationYear "1959" @default.
- W2081371249 type Work @default.
- W2081371249 sameAs 2081371249 @default.
- W2081371249 citedByCount "152" @default.
- W2081371249 countsByYear W20813712492013 @default.
- W2081371249 countsByYear W20813712492015 @default.
- W2081371249 countsByYear W20813712492020 @default.
- W2081371249 countsByYear W20813712492022 @default.
- W2081371249 crossrefType "journal-article" @default.
- W2081371249 hasAuthorship W2081371249A5012517193 @default.
- W2081371249 hasAuthorship W2081371249A5021004651 @default.
- W2081371249 hasAuthorship W2081371249A5029412010 @default.
- W2081371249 hasAuthorship W2081371249A5030371492 @default.
- W2081371249 hasConcept C112705442 @default.
- W2081371249 hasConcept C126322002 @default.
- W2081371249 hasConcept C139254425 @default.
- W2081371249 hasConcept C141071460 @default.
- W2081371249 hasConcept C176674119 @default.
- W2081371249 hasConcept C2777278314 @default.
- W2081371249 hasConcept C2777288759 @default.
- W2081371249 hasConcept C2908647359 @default.
- W2081371249 hasConcept C42219234 @default.
- W2081371249 hasConcept C71924100 @default.
- W2081371249 hasConcept C98274493 @default.
- W2081371249 hasConcept C99454951 @default.
- W2081371249 hasConceptScore W2081371249C112705442 @default.
- W2081371249 hasConceptScore W2081371249C126322002 @default.
- W2081371249 hasConceptScore W2081371249C139254425 @default.
- W2081371249 hasConceptScore W2081371249C141071460 @default.
- W2081371249 hasConceptScore W2081371249C176674119 @default.
- W2081371249 hasConceptScore W2081371249C2777278314 @default.
- W2081371249 hasConceptScore W2081371249C2777288759 @default.
- W2081371249 hasConceptScore W2081371249C2908647359 @default.
- W2081371249 hasConceptScore W2081371249C42219234 @default.
- W2081371249 hasConceptScore W2081371249C71924100 @default.
- W2081371249 hasConceptScore W2081371249C98274493 @default.
- W2081371249 hasConceptScore W2081371249C99454951 @default.
- W2081371249 hasIssue "1" @default.
- W2081371249 hasLocation W20813712491 @default.
- W2081371249 hasLocation W20813712492 @default.
- W2081371249 hasOpenAccess W2081371249 @default.
- W2081371249 hasPrimaryLocation W20813712491 @default.
- W2081371249 hasRelatedWork W2005101515 @default.
- W2081371249 hasRelatedWork W2020608454 @default.
- W2081371249 hasRelatedWork W2020661402 @default.
- W2081371249 hasRelatedWork W2042456121 @default.
- W2081371249 hasRelatedWork W2098798296 @default.
- W2081371249 hasRelatedWork W2109062965 @default.
- W2081371249 hasRelatedWork W2162599558 @default.
- W2081371249 hasRelatedWork W2166436418 @default.
- W2081371249 hasRelatedWork W2327237280 @default.
- W2081371249 hasRelatedWork W2417050782 @default.
- W2081371249 hasVolume "82" @default.
- W2081371249 isParatext "false" @default.
- W2081371249 isRetracted "false" @default.
- W2081371249 magId "2081371249" @default.
- W2081371249 workType "article" @default.